By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IncellDx, Inc. 

1700 El Camino Real

Menlo Park  California  94027  U.S.A.
Phone: 650-777-7630 Fax: 650-587-1528



Company News
IncellDx, Inc. Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO Assay 3/30/2017 6:33:13 AM
IncellDx, Inc.’s Quantitative Immuno-Oncology Assay OncoTect iO Published In New Study 10/4/2016 12:05:55 PM
Beckman Coulter, Inc. (BEC) And IncellDx, Inc. Sign Distribution Partnership To Benefit Human Papilloma Virus (HPV) Research In China, Hong Kong And Taiwan 11/13/2015 10:23:29 AM
IncellDx, Inc. Signs Exclusive License With Claremont BioSolutions To Commercialize Novel Liquid-Based Biopsy Technology 4/14/2015 12:20:04 PM
MD Anderson Cancer Center And PPRI In Early Stage Breast Cancer Studies With IncellDx, Inc. Oncobreast3Dx® Technology 1/27/2015 8:05:35 AM
IncellDx, Inc. Announces The Expansion Of Its Companion Diagnostic Program 2/25/2014 9:26:33 AM
IncellDx, Inc. Signs Agreement With Bristol-Myers Squibb Company (BMY) Related to the Development of an Assay for a Companion Diagnostic Test 10/29/2013 7:06:37 AM
IncellDx, Inc. Signs Deal With GeneCell Diagnostics to Offer New HPV Technology in India 6/21/2013 9:37:37 AM
IncellDx, Inc. Signs Deal With Kindstar Global to Offer Novel HPV Technology in China for Cervical Cancer Screening 6/11/2013 9:06:19 AM
IncellDx, Inc. Presents First Study Using Their Novel OncoBreast 3Dx™ Breast Cancer Technology 1/8/2013 9:19:39 AM